SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Kumar Prashant) srt2:(2020-2024)"

Sökning: WFRF:(Kumar Prashant) > (2020-2024)

  • Resultat 1-10 av 35
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Malik, Yashpal Singh, et al. (författare)
  • Coronavirus Disease Pandemic (COVID-19) : Challenges and a Global Perspective
  • 2020
  • Ingår i: Pathogens. - : MDPI AG. - 2076-0817. ; 9:7
  • Forskningsöversikt (refereegranskat)abstract
    • The technology-driven world of the 21st century is currently confronted with a major threat to humankind, represented by the coronavirus disease (COVID-19) pandemic, caused by the severe acute respiratory syndrome, coronavirus-2 (SARS-CoV-2). As of now, COVID-19 has affected more than 6 million confirmed cases and took 0.39 million human lives. SARS-CoV-2 spreads much faster than its two ancestors, SARS-CoV and Middle East respiratory syndrome-CoV (MERS-CoV), but has low fatality rates. Our analyses speculate that the efficient replication and transmission of SARS-CoV-2 might be due to the high-density basic amino acid residues, preferably positioned in close proximity at both the furin-like cleavage sites (S1/S2 and S2 ') within the spike protein. Given the high genomic similarities of SARS-CoV-2 to bat SARS-like CoVs, it is likely that bats serve as a reservoir host for its progenitor. Women and children are less susceptible to SARS-CoV-2 infection, while the elderly and people with comorbidities are more prone to serious clinical outcomes, which may be associated with acute respiratory distress syndrome (ARDS) and cytokine storm. The cohesive approach amongst researchers across the globe has delivered high-end viral diagnostics. However, home-based point-of-care diagnostics are still under development, which may prove transformative in current COVID-19 pandemic containment. Similarly, vaccines and therapeutics against COVID-19 are currently in the pipeline for clinical trials. In this review, we discuss the noteworthy advancements, focusing on the etiological viral agent, comparative genomic analysis, population susceptibility, disease epidemiology and diagnosis, animal reservoirs, laboratory animal models, disease transmission, therapeutics, vaccine challenges, and disease mitigation measures.
  •  
2.
  • Bryazka, D., et al. (författare)
  • Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020
  • 2022
  • Ingår i: Lancet. - 0140-6736. ; 400:10347, s. 185-235
  • Tidskriftsartikel (refereegranskat)abstract
    • Background The health risks associated with moderate alcohol consumption continue to be debated. Small amounts of alcohol might lower the risk of some health outcomes but increase the risk of others, suggesting that the overall risk depends, in part, on background disease rates, which vary by region, age, sex, and year. Methods For this analysis, we constructed burden-weighted dose-response relative risk curves across 22 health outcomes to estimate the theoretical minimum risk exposure level (TMREL) and non-drinker equivalence (NDE), the consumption level at which the health risk is equivalent to that of a non-drinker, using disease rates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2020 for 21 regions, including 204 countries and territories, by 5-year age group, sex, and year for individuals aged 15-95 years and older from 1990 to 2020. Based on the NDE, we quantified the population consuming harmful amounts of alcohol. Findings The burden-weighted relative risk curves for alcohol use varied by region and age. Among individuals aged 15-39 years in 2020, the TMREL varied between 0 (95% uncertainty interval 0-0) and 0.603 (0.400-1.00) standard drinks per day, and the NDE varied between 0.002 (0-0) and 1.75 (0.698-4.30) standard drinks per day. Among individuals aged 40 years and older, the burden-weighted relative risk curve was J-shaped for all regions, with a 2020 TMREL that ranged from 0.114 (0-0.403) to 1.87 (0.500-3.30) standard drinks per day and an NDE that ranged between 0.193 (0-0.900) and 6.94 (3.40-8.30) standard drinks per day. Among individuals consuming harmful amounts of alcohol in 2020, 59.1% (54.3-65.4) were aged 15-39 years and 76.9% (7.0-81.3) were male. Interpretation There is strong evidence to support recommendations on alcohol consumption varying by age and location. Stronger interventions, particularly those tailored towards younger individuals, are needed to reduce the substantial global health loss attributable to alcohol. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
  •  
3.
  • Cousin, E., et al. (författare)
  • Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019
  • 2022
  • Ingår i: Lancet Diabetes & Endocrinology. - : Elsevier BV. - 2213-8587. ; 10:3, s. 177-192
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Diabetes, particularly type 1 diabetes, at younger ages can be a largely preventable cause of death with the correct health care and services. We aimed to evaluate diabetes mortality and trends at ages younger than 25 years globally using data from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Methods We used estimates of GBD 2019 to calculate international diabetes mortality at ages younger than 25 years in 1990 and 2019. Data sources for causes of death were obtained from vital registration systems, verbal autopsies, and other surveillance systems for 1990-2019. We estimated death rates for each location using the GBD Cause of Death Ensemble model. We analysed the association of age-standardised death rates per 100 000 population with the Socio-demographic Index (SDI) and a measure of universal health coverage (UHC) and described the variability within SDI quintiles. We present estimates with their 95% uncertainty intervals. Findings In 2019, 16 300 (95% uncertainty interval 14 200 to 18 900) global deaths due to diabetes (type 1 and 2 combined) occurred in people younger than 25 years and 73.7% (68.3 to 77.4) were classified as due to type 1 diabetes. The age-standardised death rate was 0.50 (0.44 to 0.58) per 100 000 population, and 15 900 (97.5%) of these deaths occurred in low to high-middle SDI countries. The rate was 0.13 (0.12 to 0.14) per 100 000 population in the high SDI quintile, 0.60 (0.51 to 0.70) per 100 000 population in the low-middle SDI quintile, and 0.71 (0.60 to 0.86) per 100 000 population in the low SDI quintile. Within SDI quintiles, we observed large variability in rates across countries, in part explained by the extent of UHC (r(2)=0.62). From 1990 to 2019, age-standardised death rates decreased globally by 17.0% (-28.4 to -2.9) for all diabetes, and by 21.0% (-33.0 to -5.9) when considering only type 1 diabetes. However, the low SDI quintile had the lowest decline for both all diabetes (-13.6% [-28.4 to 3.4]) and for type 1 diabetes (-13.6% [-29.3 to 8.9]). Interpretation Decreasing diabetes mortality at ages younger than 25 years remains an important challenge, especially in low and low-middle SDI countries. Inadequate diagnosis and treatment of diabetes is likely to be major contributor to these early deaths, highlighting the urgent need to provide better access to insulin and basic diabetes education and care. This mortality metric, derived from readily available and frequently updated GBD data, can help to monitor preventable diabetes-related deaths over time globally, aligned with the UN's Sustainable Development Targets, and serve as an indicator of the adequacy of basic diabetes care for type 1 and type 2 diabetes across nations. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
  •  
4.
  •  
5.
  •  
6.
  •  
7.
  • Prashant, Kumar, et al. (författare)
  • Development of a Reliable Machine Learning Model to Predict Compressive Strength of FRP-Confined Concrete Cylinders
  • 2023
  • Ingår i: Buildings. - : MDPI. - 2075-5309. ; 13:4
  • Tidskriftsartikel (refereegranskat)abstract
    • The degradation of reinforced concrete (RC) structures has raised major concerns in the concrete industry. The demolition of existing structures has shown to be an unsustainable solution and leads to many financial concerns. Alternatively, the strengthening sector has put forward many sustainable solutions, such as the retrofitting and rehabilitation of existing structural elements with fiber-reinforced polymer (FRP) composites. Over the past four decades, FRP retrofits have attracted major attention from the scientific community, thanks to their numerous advantages such as having less weight, being non-corrodible, etc., that help enhance the axial, flexural, and shear capacities of RC members. This study focuses on predicting the compressive strength (CS) of FRP-confined concrete cylinders using analytical models and machine learning (ML) models. To achieve this, a total of 1151 specimens of cylinders have been amassed from comprehensive literature studies. The ML models utilized in the study are Gaussian process regression (GPR), support vector machine (SVM), artificial neural network (ANN), optimized SVM, and optimized GPR models. The input parameters that have been used for prediction include the geometrical characteristics of specimens, the mechanical properties of FRP composite, and the CS of concrete. The results of the five ML models are compared with nineteen analytical models. The results evaluated from the ML algorithms imply that the optimized GPR model has been found to be the best among all other models, demonstrating a higher correlation coefficient, root mean square error, mean absolute percentage error, mean absolute error, a-20 index, and Nash–Sutcliffe efficiency values of 0.9960, 3.88 MPa, 3.11%, 2.17 MPa, 0.9895, and 0.9921, respectively. The R-value of the optimized GPR model is 0.37%, 0.03%, 5.14%, and 2.31% higher than that of the ANN, GPR, SVM, and optimized SVM models, respectively, whereas the root mean square error value of the ANN, GPR, SVM, and optimized SVM models is, respectively, 81.04%, 12.5%, 471.77%, and 281.45% greater than that of the optimized GPR model.
  •  
8.
  •  
9.
  •  
10.
  • Sharma, R., et al. (författare)
  • Global, regional, and national burden of colorectal cancer and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
  • 2022
  • Ingår i: Lancet Gastroenterology & Hepatology. - : Elsevier BV. - 2468-1253. ; 7:7, s. 627-647
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Colorectal cancer is the third leading cause of cancer deaths worldwide. Given the recent increasing trends in colorectal cancer incidence globally, up-to-date information on the colorectal cancer burden could guide screening, early detection, and treatment strategies, and help effectively allocate resources. We examined the temporal patterns of the global, regional, and national burden of colorectal cancer and its risk factors in 204 countries and territories across the past three decades. Methods Estimates of incidence, mortality, and disability-adjusted life years (DALYs) for colorectal cancer were generated as a part of the Global Burden of Diseases, Injuries and Risk Factors Study (GBD) 2019 by age, sex, and geographical location for the period 1990-2019. Mortality estimates were produced using the cause of death ensemble model. We also calculated DALYs attributable to risk factors that had evidence of causation with colorectal cancer. Findings Globally, between 1990 and 2019, colorectal cancer incident cases more than doubled, from 842 098 (95% uncertainty interval [UI] 810 408-868 574) to 2.17 million (2.00-2.34), and deaths increased from 518 126 (493 682-537 877) to 1.09 million (1.02-1.15). The global age-standardised incidence rate increased from 22.2 (95% UI 21.3-23.0) per 100 000 to 26.7 (24.6-28.9) per 100 000, whereas the age-standardised mortality rate decreased from 14.3 (13.5-14.9) per 100 000 to 13.7 (12.6-14.5) per 100 000 and the age-standardised DALY rate decreased from 308.5 (294.7-320.7) per 100 000 to 295.5 (275.2-313.0) per 100 000 from 1990 through 2019. Taiwan (province of China; 62.0 [48.9-80.0] per 100 000), Monaco (60.7 [48.5-73.6] per 100 000), and Andorra (56.6 [42.8-71.9] per 100 000) had the highest age-standardised incidence rates, while Greenland (31.4 [26.0-37.1] per 100 000), Brunei (30.3 [26.6-34.1] per 100 000), and Hungary (28.6 [23.6-34.0] per 100 000) had the highest age-standardised mortality rates. From 1990 through 2019, a substantial rise in incidence rates was observed in younger adults (age <50 years), particularly in high Socio-demographic Index (SDI) countries. Globally, a diet low in milk (15.6%), smoking (13.3%), a diet low in calcium (12.9%), and alcohol use (9.9%) were the main contributors to colorectal cancer DALYs in 2019. Interpretation The increase in incidence rates in people younger than 50 years requires vigilance from researchers, clinicians, and policy makers and a possible reconsideration of screening guidelines. The fast-rising burden in low SDI and middle SDI countries in Asia and Africa calls for colorectal cancer prevention approaches, greater awareness, and cost-effective screening and therapeutic options in these regions. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 35
Typ av publikation
tidskriftsartikel (30)
forskningsöversikt (4)
konferensbidrag (1)
Typ av innehåll
refereegranskat (35)
Författare/redaktör
Arabloo, J (17)
Fischer, F (17)
Golechha, M (17)
Ahmad, S. (16)
Ancuceanu, R (16)
Bhattacharyya, K (16)
visa fler...
Ghashghaee, A (16)
Saddik, B (16)
Sahebkar, A (16)
Sathian, B (16)
Kumar, N. (15)
Rezaei, N (15)
Abbasi-Kangevari, M (15)
Hosseinzadeh, M (15)
Mohammadian-Hafsheja ... (15)
Monasta, L (15)
Yonemoto, N (15)
Elhadi, M (15)
Rahman, M (15)
Barrow, A. (15)
Alipour, V (14)
Alvis-Guzman, N (14)
Dandona, L (14)
Dandona, R (14)
Diaz, D (14)
Filip, I (14)
Foroutan, M (14)
Joo, T (14)
Koyanagi, A (14)
Majeed, A (14)
Mohammed, S (14)
Oancea, B (14)
Radfar, A (14)
Rawaf, S (14)
Misra, S (14)
Ahmadi, S (14)
Al Hamad, H. (14)
Gupta, S. (13)
Alahdab, F (13)
Bhardwaj, P (13)
Herteliu, C (13)
Holla, R (13)
Hostiuc, M (13)
Jakovljevic, M (13)
Kabir, A (13)
Landires, I (13)
Mestrovic, T (13)
Naghavi, M (13)
Pana, A (13)
Thapar, R (13)
visa färre...
Lärosäte
Karolinska Institutet (12)
Göteborgs universitet (10)
Uppsala universitet (7)
Lunds universitet (4)
Luleå tekniska universitet (2)
Kungliga Tekniska Högskolan (1)
visa fler...
Stockholms universitet (1)
Högskolan i Gävle (1)
Mälardalens universitet (1)
Chalmers tekniska högskola (1)
Högskolan i Borås (1)
visa färre...
Språk
Engelska (35)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (16)
Naturvetenskap (8)
Teknik (5)
Samhällsvetenskap (1)
Humaniora (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy